← Leaderboards
Lloyd M Yu
Planet Biotechnology, Inc.
$2,044,824
Attributed
$3,989,647
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2011–13$2M$1.5M$1M$500K$0
'11
'12
'13
Funding mix
By agency
NIH$3,989,647 · 2
By mechanism
R01$3,889,647 · 1
R43$100,000 · 1
Top collaborators
- Keith Wycoff3 shared
Most similar at Planet Biotechnology, Inc.
Same institution · by research overlap
- Keith Wycoff$31,110,743
Others in their field
Top investigators on “Tobacco”
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Lloyd D Johnston · University Of Michigan At Ann Arbor$67,097,167
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$55,710,357
- Richard A Miech · Johns Hopkins University$51,772,192
- Stephen T Higgins · University Of Vermont &St Agric College$45,191,145
- Stephen S Hecht · University Of Minnesota$41,546,048
Research focus
TobaccoAnthrax DiseaseBiological ModelsAnimal RuleAntibioticsAntibody FormationAntigen ReceptorsAntigensApplications GrantsAntibiotic ResistanceBacillus Anthracis SporeBaseBinding (Molecular Function)BiodefenseAnthrax ToxinBiological ProductsBlood CapillariesCaliforniaCapillaryCategoriesBacillus AnthracisChimera OrganismCiprofloxacinAffinity
Grant awards (4)
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against$1,145,064
R01 · FY2013 · AI · contact PI
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against$1,166,055
R01 · FY2012 · AI · contact PI
cGMP manufacturing of PBI-220, a broad spectrum immunoadhesin therapeutic against$1,578,528
R01 · FY2011 · AI · contact PI
A SPLIT-SELECTABLE MARKER FOR MULTIGENE TRANSFORMATIONS$100,000
R43 · FY2001 · AI